Search results for "OUTCOME"

showing 10 items of 5148 documents

Current practice of hepatitis C treatment in Southern Italy.

2010

Abstract Background Only a small proportion of subjects referring to hospitals for hepatitis C virus (HCV) positivity receives antiviral therapy. Aim To evaluate the rate of antiviral treatment and the causes for no treatment in HCV-RNA positive subjects seen in hospital settings. Patients and methods A prospective study enrolling over a 6-month period (February–July 2009) all consecutive anti-HCV positive subjects initially referred (naive patients) to 12 liver units in Southern Italy for HCV treatment. Results Out of 608 subjects evaluated, 74 (12.2%) had no detectable HCV-RNA in the serum and thus were excluded. Of the remaining 534 HCV-RNA positive subjects, 357 (66.9%) were not treated…

AdultMalemedicine.medical_specialtyMultivariate analysisHepatitis C virusAlcohol abuseHepacivirusInterferon alpha-2medicine.disease_causeAntiviral AgentsPolyethylene GlycolsTreatment RefusalSex FactorsInternal medicineRibavirinHumansMedicineProspective StudiesProspective cohort studyAgedHepatologybusiness.industryGastroenterologyAntiviral therapyInterferon-alphaAlanine TransaminaseHepatitis CHepatitis C AntibodiesMiddle Agedmedicine.diseaseHepatitis CRecombinant ProteinsAlcoholismTreatment OutcomeItalyCurrent practiceImmunologyHCVHcv treatmentEducational StatusRNA ViralFemalebusiness
researchProduct

Association of elevated serum triglyceride levels with a more severe course of acute pancreatitis: Cohort analysis of 1457 patients.

2019

Previous publications have reported an association between hypertriglyceridemia (HTG) and severity of acute pancreatitis, but this relationship remains somewhat controversial.To evaluate the outcome of acute pancreatitis according to serum triglyceride levels on admission.Retrospective analysis of prospectively collected data, which included all consecutive cases of acute pancreatitis admitted to a tertiary hospital (January 2002-December 2014). Acute pancreatitis patients were classified into 3 groups based on serum triglyceride levels (mg/dl) measured within 48 h from admission: normal triglycerides-mild HTG (200); moderate HTG (200-749); severe HTG (≥750). Primary outcomes were the diffe…

AdultMalemedicine.medical_specialtyMultivariate analysisNecrosisAdolescentEndocrinology Diabetes and MetabolismMultiple Organ FailureGastroenterologyCohort Studies03 medical and health scienceschemistry.chemical_compoundYoung Adult0302 clinical medicineRisk FactorsInternal medicinemedicineHumansPancreasTriglyceridesAgedRetrospective StudiesAged 80 and overHypertriglyceridemiaHepatologyTriglyceridebusiness.industryPancreatitis Acute NecrotizingHypertriglyceridemiaGastroenterologyMiddle Agedmedicine.diseasePrognosisTreatment OutcomechemistryPancreatitis030220 oncology & carcinogenesisAcute DiseaseAcute pancreatitisPancreatitis030211 gastroenterology & hepatologyFemalemedicine.symptomSevere coursebusinessCohort studyPancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
researchProduct

Long-term results (7 to 10 years) of endoscopic papillotomy for choledocholithiasis. Multivariate analysis of prognostic factors for the recurrence o…

1998

Abstract Background: The long-term outcome after endoscopic papillotomy is poorly defined. The aim of this study was to determine the long-term results of this method in the treatment of common duct calculi and to determine which prognostic factors are associated with the relapse of biliary symptoms. Methods: Between 1985 and 1988, 223 consecutive (149 women, mean age 67.9 years) patients underwent endoscopic papillotomy for duct stones; 127 had already undergone cholecystectomy or underwent this operation during the same hospitalization. Follow-up data were obtained retrospectively from the patients and patients' relatives and general practitioners. Results: The procedure was successful in…

AdultMalemedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentGallstonesGastroenterologyDisease-Free SurvivalSphincterotomy EndoscopicPostoperative ComplicationsRecurrenceInternal medicinemedicineHumansRadiology Nuclear Medicine and imagingAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testBile ductbusiness.industryGallbladderGastroenterologyRetrospective cohort studyMiddle AgedPrognosisSurgeryEndoscopymedicine.anatomical_structureTreatment OutcomeBiliary tractMultivariate AnalysisCholecystectomyFemalebusinessDuct (anatomy)Follow-Up StudiesGastrointestinal endoscopy
researchProduct

Resective surgical approach shows a high performance in the management of advanced cases of bisphosphonate-related osteonecrosis of the jaws: a retro…

2012

Abstract PURPOSE: The aim of this study was to evaluate the results of the surgical treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in a large cohort. MATERIALS AND METHODS: A retrospective cohort multicenter study was designed. Patients were enrolled if they were diagnosed with BRONJ and received operative treatment. Data on demographic, health status, perioperative, and surgical factors were collected retrospectively. The primary outcome variable was a change in BRONJ staging (improvement, worsening, or no change). Interventions were grouped by local debridement and resective surgery. Data were collected for other variables as cofactors. Univariate analysis and logist…

AdultMalemedicine.medical_specialtyMultivariate analysismedicine.medical_treatmentLogistic regressionSettore MED/28 - Malattie OdontostomatologicheHumansMedicinebisphosphonate-related osteonecrosis of the jawsAgedRetrospective StudiesAnalysis of VarianceUnivariate analysisChi-Square Distributionbusiness.industryRetrospective cohort studyPerioperativeMiddle AgedBisphosphonatemedicine.diseaseOsteotomySurgeryTreatment OutcomeDebridementItalyOtorhinolaryngologySurgical Procedures OperativeTooth ExtractionRegression AnalysisBisphosphonate-Associated Osteonecrosis of the JawFemaleSurgeryOral SurgerybusinessOsteonecrosis of the jawChi-squared distribution
researchProduct

Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction

2009

Abstract Introduction The association of the temporal evolution of cardiac necrosis marker release with cardiovascular magnetic resonance-derived microvascular perfusion after ST-elevation myocardial infarction is unknown. Methods We analyzed 163 patients with a first ST-elevation myocardial infarction and a patent infarct-related artery treated with thrombolysis (67%) or primary angioplasty (33%). Using first-pass perfusion CMR, abnormal perfusion was defined as a lack of contrast arrival into the infarct area in > 1 segment. Troponin I, creatine kinase MB and myoglobin were measured upon arrival and at 6, 12, 24, 48 and 96 hours after reperfusion. Results Abnormal perfusion was detected i…

AdultMalemedicine.medical_specialtyMyocardial InfarctionMyocardial Reperfusion InjuryCoronary AngiographyNecrosisReperfusion therapyInternal medicineTroponin ImedicineCreatine Kinase MB FormHumansProspective StudiesMyocardial infarctionAngioplasty Balloon CoronaryAgedmedicine.diagnostic_testbiologyMyoglobinbusiness.industryMyocardiumST elevationMagnetic resonance imagingHematologyMiddle AgedPrognosismedicine.diseaseMagnetic Resonance ImagingTroponinTroponinTreatment Outcomebiology.proteinCardiologyFemaleCreatine kinasebusinessPerfusionBiomarkersThrombosis Research
researchProduct

An 18-Month Follow-up, Randomized Comparison of Effectiveness and Safety of Two Hyaluronic Acid Fillers for Treatment of Moderate Nasolabial Folds

2016

Hyaluronic acid (HA) filler injection is a popular nonsurgical aesthetic procedure.To compare the effectiveness and safety of 2 hyaluronic acid fillers (HAEC and HARES) for treatment of moderate nasolabial folds (NLFs).This was an evaluator- and subject-blinded split-face study. HAEC or HARES was randomly assigned to the left or right NLF at baseline. Retreatment was performed after 9 months; follow-up extended to 18 months after baseline (9 months after retreatment). Effectiveness assessments included the Wrinkle Severity Rating Scale (WSRS) and subject preference. Safety assessments included adverse events (AEs) and local tolerability symptoms recorded by subjects during 3 weeks after tre…

AdultMalemedicine.medical_specialtyNasolabial FoldTime FactorsTreatment outcomeDermatology030230 surgerylaw.invention030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodRandomized controlled triallawDermal FillersHyaluronic acidmedicineHumansHyaluronic AcidAgedbusiness.industryFollow up studiesPatient PreferenceGeneral MedicineMiddle AgedNasolabial foldPatient preferenceSkin AgingSurgeryTreatment Outcomemedicine.anatomical_structureMulticenter studychemistryRetreatmentFemaleSurgerybusinessFollow-Up StudiesMonth follow upDermatologic Surgery
researchProduct

Mirtazapine compared with paroxetine in major depression.

2000

Background: The aim was to compare the efficacy and tolerability of mirtazapine with those of paroxetine. Method: 275 outpatients with a diagnosis of major depressive episode (DSM-IV) and a score ≥ 18 on the 17-item Hamilton Rating Scale for Depression (HAM-D-17) were randomly assigned to 6 weeks of treatment with mirtazapine (15-45 mg/day) or paroxetine (20-40 mg/day). Efficacy was assessed by the HAM-D-17, Hamilton Rating Scale for Anxiety (HAM-A), and Clinical Global Impressions scales (Severity and Improvement), and analyses were performed on the intent-to-treat sample (127 mirtazapine-treated patients and 123 paroxetine-treated patients). Results: Mean daily doses were 32.7 mg of mirta…

AdultMalemedicine.medical_specialtyNauseaMirtazapineMirtazapineMianserinAntidepressive Agents TricyclicSeverity of Illness IndexDrug Administration Schedulelaw.inventionRandomized controlled trialDouble-Blind MethodlawInternal medicinemedicineAmbulatory CareHumansPsychiatryMajor depressive episodeAgedPsychiatric Status Rating ScalesDepressive DisorderHamilton Rating Scale for DepressionMiddle AgedParoxetinePsychiatry and Mental healthParoxetineTreatment OutcomeTolerabilityAnxietyFemalemedicine.symptomPsychologymedicine.drugThe Journal of clinical psychiatry
researchProduct

Diabetes and hyperglycemia as risk factors for postoperative outcome in maxillofacial surgery.

2017

Abstract Background Aim of this study was to investigate the frequency of complications in maxillofacial surgery in-patients in correlation to diabetes mellitus or a pathologically altered glucose metabolism. Materials and methods All patients' electronic health records were analyzed retrospectively. Diabetes mellitus anamnesis, the treatment regime, blood glucose levels, and the duration of inpatient treatment were recorded. Glucose readings ≥200 mg/dL measured at any time and fasting glucose levels of ≥110 mg/dL were defined as hyperglycemic. Noted complications were infection, dehiscence, swelling, and necrosis. Results 8.7% out of 1374 patients had a known diabetes diagnosis. 13.0% had …

AdultMalemedicine.medical_specialtyNecrosisDehiscenceCarbohydrate metabolismDiabetes Complications03 medical and health sciencesYoung Adult0302 clinical medicinePostoperative ComplicationsDiabetes mellitusGermanymedicinePostoperative outcomeHumansIn patient030212 general & internal medicineAgedRetrospective StudiesAnamnesisbusiness.industryOrthognathic Surgical Procedures030206 dentistryMiddle Agedmedicine.diseaseSurgeryHyperglycemiaSurgeryFemalemedicine.symptomComplicationbusinessThe Journal of surgical research
researchProduct

High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdraw…

2013

Few data exist on using thyrotropin alfa (recombinant human thyroid-stimulating hormone [rhTSH]) with radioiodine for thyroid remnant ablation of patients who have T4 primary tumors (invasion beyond the thyroid capsule).A retrospective chart review protocol at nine centers in Europe was set up with special waiver of need for informed consent, along with a careful procedure to avoid selection bias when enrolling patients into the database. Data on 144 eligible patients with T4 tumors were collected (T4, N0-1, M0-1; mean age 49.7 years; 65% female; 88% papillary cancer). All had received (131)I remnant ablation following TSH stimulation with rhTSH or thyroid hormone withdrawal (THW) since Jan…

AdultMalemedicine.medical_specialtyNeoplasm ResidualEndocrinology Diabetes and Metabolismmedicine.medical_treatmentUrologyRemnant ablationIodine RadioisotopesYoung AdultEndocrinologyClinical endpointmedicineHumansThyroid NeoplasmsThyrotropin AlfaThyroid cancerAgedRetrospective StudiesAged 80 and overHigh risk patientsbusiness.industryThyroidCancerMiddle Agedmedicine.diseaseAblationCombined Modality TherapySurgeryTreatment Outcomemedicine.anatomical_structureThyroidectomyFemalebusinessHormoneThyroid
researchProduct

Transoral transclival removal of anteriorly placed cavernous malformations of the brainstem.

2001

BACKGROUND The natural history of brain stem cavernous malformations is unfavorable because of their high hemorrhage rate and resulting neurological deterioration among patients. However, direct surgery of intrinsic and anteriorly situated cavernomas is hazardous and leads to a bad postoperative outcome because of trauma to lateral and dorsally situated eloquent areas of the brain stem. METHODS We review the cases of two patients with symptomatic cavernous malformations of the anterior brain stem and describe the usefulness of a transoral-transclival approach. A 23-year-old man developed progressive hemihypaesthesia and paraesthesia, hemiparesis with gait ataxia, dysarthria, dysphonia, and …

AdultMalemedicine.medical_specialtyNeurological examinationNeurosurgical ProceduresCentral nervous system diseaseClivusmedicineHumansDiplopiaMouthmedicine.diagnostic_testbusiness.industryBrain NeoplasmsCavernous malformationsmedicine.diseaseMagnetic Resonance ImagingSurgerymedicine.anatomical_structureHemiparesisHemangioma CavernousTreatment OutcomeCranial Fossa PosteriorGait AtaxiaSurgeryFemaleNeurology (clinical)medicine.symptombusinessTomography X-Ray ComputedMeningitisBrain StemSurgical neurology
researchProduct